Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Viatris Inc. (VTRS : NSDQ)
 
 • Company Description   
Viatris Inc. is a healthcare company. It provides access to medicines, advance sustainable operations, develop solutions and leverage to connect more people to more products and services through Global Healthcare Gateway(TM). Viatris Inc., formerly known as Mylan NV, is based in PITTSBURGH.

Number of Employees: 37,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $11.53 Daily Weekly Monthly
20 Day Moving Average: 14,239,432 shares
Shares Outstanding: 1,212.35 (millions)
Market Capitalization: $13,978.39 (millions)
Beta: 1.29
52 Week High: $15.92
52 Week Low: $9.66
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 12.05% 18.69%
12 Week 13.60% 24.11%
Year To Date -14.78% 3.05%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
1000 MYLAN BOULEVARD
-
CANONSBURG,PA 15317
USA
ph: 724-514-1800
fax: 724-514-1870
investorrelations@viatris.com http://www.viatris.com/en
 
 • General Corporate Information   
Officers
Michael Goettler - Chief Executive Officer
Robert J. Coury - Executive Chairman
Sanjeev Narula - Chief Financial Officer
W. Don Cornwell - Director
JoEllen Lyons Dillon - Director

Peer Information
Viatris Inc. (CHCR)
Viatris Inc. (ESRX)
Viatris Inc. (MYDP)
Viatris Inc. (GBCS)
Viatris Inc. (LAXAF)
Viatris Inc. (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 92556V106
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/08/22
Share - Related Items
Shares Outstanding: 1,212.35
Most Recent Split Date: 10.00 (1.50:1)
Beta: 1.29
Market Capitalization: $13,978.39 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 4.16%
Current Fiscal Quarter EPS Consensus Estimate: $0.81 Indicated Annual Dividend: $0.48
Current Fiscal Year EPS Consensus Estimate: $3.46 Payout Ratio: 0.13
Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: 0.11
Estmated Long-Term EPS Growth Rate: 6.75% Last Dividend Paid: 02/23/2022 - $0.12
Next EPS Report Date: 08/08/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 3.33
Trailing 12 Months: 3.12
PEG Ratio: 0.49
Price Ratios
Price/Book: 0.68
Price/Cash Flow: 1.55
Price / Sales: 0.79
EPS Growth
vs. Year Ago Period: 1.09%
vs. Previous Quarter: 16.25%
Sales Growth
vs. Year Ago Period: -5.39%
vs. Previous Quarter: -3.45%
ROE
03/31/22 - 21.50
12/31/21 - 21.21
09/30/21 - 19.84
ROA
03/31/22 - 8.05
12/31/21 - 7.84
09/30/21 - 7.33
Current Ratio
03/31/22 - 1.22
12/31/21 - 1.10
09/30/21 - 1.12
Quick Ratio
03/31/22 - 0.82
12/31/21 - 0.70
09/30/21 - 0.72
Operating Margin
03/31/22 - 25.37
12/31/21 - 24.98
09/30/21 - 25.05
Net Margin
03/31/22 - 0.95
12/31/21 - -7.10
09/30/21 - -11.19
Pre-Tax Margin
03/31/22 - 1.72
12/31/21 - -3.71
09/30/21 - -8.59
Book Value
03/31/22 - 16.87
12/31/21 - 16.94
09/30/21 - 17.48
Inventory Turnover
03/31/22 - 2.80
12/31/21 - 2.82
09/30/21 - 2.62
Debt-to-Equity
03/31/22 - 1.01
12/31/21 - 1.06
09/30/21 - 1.04
Debt-to-Capital
03/31/22 - 50.24
12/31/21 - 51.37
09/30/21 - 50.89
 

Powered by Zacks Investment Research ©